B
12.66
0.13 (1.04%)
市场趋势
短期 | 中期 | ||
行业 | Medical Devices (US) | 看跌 | 看跌 |
Medical Devices (全球的) | 看跌 | 看跌 | |
股票 | Beta Bionics, Inc. | 看跌 | - |
AIStockmoo 评分
-0.8
分析师共识 | 1.0 |
内部交易活动 | -2.5 |
价格波动 | -2.0 |
技术平均移动指标 | -2.5 |
技术振荡指标 | 2.0 |
平均 | -0.80 |
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet. |
|
部门 | Healthcare |
行业 | Medical Devices |
投资方式 | Small Value |
内部持股比例 | 6.51% |
机构持股比例 | 98.41% |
52周波幅 | ||
目标价格波幅 | ||
高 | 30.00 (Lake Street, 136.97%) | 购买 |
中 | 21.00 (65.88%) | |
低 | 17.00 (Baird, 34.28%) | 保留 |
平均值 | 22.67 (79.07%) | |
总计 | 2 购买, 1 保留 | |
平均价格@调整类型 | 17.67 |
公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
---|---|---|---|---|
Baird | 30 Jul 2025 | 17.00 (34.28%) | 保留 | 16.76 |
Truist Securities | 30 Jul 2025 | 21.00 (65.88%) | 购买 | 16.76 |
16 Jun 2025 | 26.00 (105.37%) | 购买 | 19.45 | |
Lake Street | 12 Jun 2025 | 30.00 (136.97%) | 购买 | 19.49 |
名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
---|---|---|---|---|
FEIDER STEPHEN | - | 16.47 | -10,000 | -163,963 |
HOPMAN MARK | - | 15.88 | -16,158 | -256,589 |
累积净数量 | -26,158 | |||
累积净值 ($) | -420,552 | |||
累积平均购买 ($) | - | |||
累积平均卖出 ($) | 16.27 |
名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
---|---|---|---|---|---|---|
FEIDER STEPHEN | 职员 | 22 Aug 2025 | 自动卖出 (-) | 4,413 | 17.05 | 75,242 |
FEIDER STEPHEN | 职员 | 22 Aug 2025 | 执行期权 | 4,413 | - | - |
HOPMAN MARK | 职员 | 19 Aug 2025 | 自动卖出 (-) | 16,158 | 15.88 | 256,589 |
HOPMAN MARK | 职员 | 19 Aug 2025 | 执行期权 | 16,158 | - | - |
FEIDER STEPHEN | 职员 | 19 Aug 2025 | 自动卖出 (-) | 5,587 | 15.88 | 88,722 |
FEIDER STEPHEN | 职员 | 19 Aug 2025 | 执行期权 | 5,587 | - | - |
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合